Ferroptosis in Vascular Diseases: A Mechanistic and Immunological Perspective on Therapeutic Targeting
Antioxidants · 17.04.2026 · 15 (4) · 502
DOI: 10.3390/antiox15040502 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 17.04.2026. Verfasst von Yiyang Cui und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Queen Mary School, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330031, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangxi Province, Health Commission of Jiangxi province, the Jiangxi Province Key Laboratory of bioengineering drugs.
Abstract (Originalsprache)
Vascular diseases impose a heavy global burden, yet existing therapies have limitations, necessitating novel drug targets. Ferroptosis, an iron-dependent, lipid peroxidation-driven form of cell death, acts not only as an initiator of metabolic collapse but also as a sterile inflammatory trigger by releasing damage-associated molecular patterns (DAMPs) and activating pro-inflammatory pathways. In this paper, we propose the “ferroptosis–inflammation circuit” as a self-amplifying loop where ferroptosis fuels inflammation and the inflammatory microenvironment reciprocally promotes ferroptosis via cell type-specific mechanisms. Although ferroptosis in cardiovascular diseases has been reviewed, its immunopathological role in specific vascular diseases and how macrophages, neutrophils, T cells, and vascular cells collaboratively drive pathology through this circuit remains underexplored. The unique perspective of this review is a systematic focus on the dynamic interplay between ferroptosis and immune responses within the vascular wall, moving beyond static metabolic descriptions. We synthesize evidence linking ferroptosis to atherosclerosis, pulmonary hypertension, stroke, aneurysms, and aortic dissection, emphasizing its immunological dimension across cell types. By defining the ferroptosis–inflammation circuit and its cell type-specific patterns, we reposition ferroptosis as a core pathological hub that couples metabolic dysregulation, immune activation, and vascular remodeling. Understanding this circuit may open novel therapeutic avenues for targeting the ferroptosis–immune interface.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Queen Mary School, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330031, China.
- Jiangxi Province Key Laboratory of Bioengineering Drugs, The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang Uni…
Förderung
- Natural Science Foundation of Jiangxi Province
- Health Commission of Jiangxi province
- the Jiangxi Province Key Laboratory of bioengineering drugs
- Jiangxi Province Key Laboratory of Bioengineering Drugs
Zitieren
APA
Cui, Y., Zhu, P., & Jiang, M. (2026). Ferroptosis in Vascular Diseases: A Mechanistic and Immunological Perspective on Therapeutic Targeting. Antioxidants, 15(4), 502. https://doi.org/10.3390/antiox15040502
Vancouver
Cui Y, Zhu P, Jiang M. Ferroptosis in Vascular Diseases: A Mechanistic and Immunological Perspective on Therapeutic Targeting. Antioxidants. 2026;15(4):502. doi:10.3390/antiox15040502
BibTeX
@article{Cui2026,
author = {Cui, Yiyang and Zhu, Pengyan and Jiang, Meixiu},
title = {Ferroptosis in Vascular Diseases: A Mechanistic and Immunological Perspective on Therapeutic Targeting},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {4},
pages = {502},
doi = {10.3390/antiox15040502}
}
EUVIMED